Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2008-06-26

Clinical Trial Update: Liposomal Anthracyclin in the Treatment of Elderly ALL [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating liposomal anthracyclin in elderly patients with Acute Lymphoblastic Leukemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Liposomal Anthracyclin

Snippet

Sponsor: French Innovative Leukemia Organisation | Conditions: Acute Lymphoblastic Leukemia | Phase 2 | Status: COMPLETED